Abstract
Purpose
We conducted a National Cancer Database (NCDB) study to investigate the epidemiological characteristics and identify predictors of outcomes associated with geriatric meningiomas.
Methods
The NCDB was queried for adults aged 60–89 years diagnosed between 2010 and 2017 with grade 2 and 3 meningiomas. The patients were classified into three age groups based on their age: 60–69 (hexagenarians), 70–79 (septuagenarians), and 80–89 (octogenarians). The log-rank test was utilized to compare the differences in overall survival (OS). Univariate and multivariate Cox proportional hazards regressions were used to evaluate the mortality risk associated with various patient and disease parameters.
Results
A total of 6585 patients were identified. Hexagenerians were the most common age group (49.8%), with the majority of meningiomas being classified as grade 2 (89.5%). The incidence of high-grade meningiomas increased in all age groups during the study period. Advanced age, male sex, black race, lower socioeconomic status, Charlson-Deyo score ≥ 2, and higher tumor grade were independent factors of poor survival. Among the modes of treatment, the extent of surgical resection, adjuvant radiotherapy, and treatment at a noncommunity cancer program were linked with better outcomes.
Conclusion
In geriatric patients with high-grade meningiomas, the greater extent of surgical resection and radiotherapy are associated with improved survival. However, the management and outcome of geriatric patients with higher-grade meningiomas are also associated with several socioeconomic factors.
Data availability
Restrictions apply to the availability of these data. Data were obtained from the NCDB, a prospectively maintained repository collaboratively developed by the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society.
References
Achey RL, Gittleman H, Schroer J et al (2019) Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the Central Brain Tumor Registry of the United States. Neuro Oncol 21:380–391. https://doi.org/10.1093/neuonc/noy162
Ahmeti H, Borzikowsky C, Hollander D et al (2021) Risks and neurological benefits of meningioma surgery in elderly patients compared to young patients. J Neurooncol 154:335–344. https://doi.org/10.1007/s11060-021-03832-5
Amoo M, Henry J, Farrell M, Javadpour M (2023) Meningioma in the elderly. Neuro-Oncology. Advances 5:i13–i25. https://doi.org/10.1093/noajnl/vdac107
Anakwenze CP, McGovern S, Taku N et al (2020) Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurgery 141:e133–e144. https://doi.org/10.1016/j.wneu.2020.05.030
Behling F (2022) Commentary: Racial and Socioeconomic Disparities in Patients With Meningioma: A Retrospective Cohort Study. Neurosurgery 90:e7–e8. https://doi.org/10.1227/NEU.0000000000001752
Boviatsis EJ, Bouras TI, Kouyialis AT et al (2007) Impact of age on complications and outcome in meningioma surgery. Surg Neurol 68:407–411. https://doi.org/10.1016/j.surneu.2006.11.071
Brewster R, Deb S, Pendharkar AV et al (2022) The effect of socioeconomic status on age at diagnosis and overall survival in patients with intracranial meningioma. Int J Neurosci 132:413–420. https://doi.org/10.1080/00207454.2020.1818742
Brokinkel B, Holling M, Spille DC et al (2017) Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients. JNS 126:1201–1211. https://doi.org/10.3171/2016.2.JNS152611
Buerki RA, Horbinski CM, Kruser T et al (2018) An overview of meningiomas. Future Oncol 14:2161–2177. https://doi.org/10.2217/fon-2018-0006
Buuren SV, Groothuis-Oudshoorn K (2011) Mice Multivariate Imputation by Chained Equations in R. J Stat Soft 45:3. https://doi.org/10.18637/jss.v045.i03
Cahill KS, Claus EB (2011) Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute: Clinical article. JNS 115:259–267. https://doi.org/10.3171/2011.3.JNS101748
Cao J, Yan W, Li G et al (2022) Incidence and survival of benign, borderline, and malignant meningioma patients in the United States from 2004 to 2018. Intl Journal of Cancer 151:1874–1888. https://doi.org/10.1002/ijc.34198
Champeaux-Depond C, Weller J, Froelich S, Resche-Rigon M (2021) A nationwide population-based study on overall survival after meningioma surgery. Cancer Epidemiol 70:101875. https://doi.org/10.1016/j.canep.2020.101875
Da Broi M, Borrelli P, Meling TR (2021) Predictors of Survival in Atypical Meningiomas. Cancers 13:1970. https://doi.org/10.3390/cancers13081970
Dincer A, Morales-Valero SF, Robert SM et al (2023) Surgical strategies for intracranial meningioma in the molecular era. J Neurooncol 162:253–265. https://doi.org/10.1007/s11060-023-04272-z
Ekşi MŞ, Canbolat Ç, Akbaş A et al (2019) Elderly Patients with Intracranial Meningioma: Surgical Considerations in 228 Patients with a Comprehensive Analysis of the Literature. World Neurosurgery 132:e350–e365. https://doi.org/10.1016/j.wneu.2019.08.150
Feng S, Li J, Fan F et al (2022) Prognostic Factors and Treatment Strategies for Elderly Patients with Malignant Meningioma: A SEER Population-Based Study. Front Oncol 12:913254. https://doi.org/10.3389/fonc.2022.913254
Galhom AE, Madawi AA, Ellabban MM (2018) Surgical outcomes and predictors of complication in elderly patients with meningiomas. Egypt J Neurol Psychiatry Neurosurg 54:3. https://doi.org/10.1186/s41983-018-0005-3
Garzon-Muvdi T, Yang W, Lim M et al (2017) Atypical and anaplastic meningioma: outcomes in a population based study. J Neurooncol 133:321–330. https://doi.org/10.1007/s11060-017-2436-6
Ghaffari-Rafi A, Mehdizadeh R, Ko AWK et al (2021) Demographic and socioeconomic disparities of benign cerebral meningiomas in the United States. J Clin Neurosci 86:122–128. https://doi.org/10.1016/j.jocn.2021.01.023
Goldbrunner R, Stavrinou P, Jenkinson MD et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821–1834. https://doi.org/10.1093/neuonc/noab150
Gwyther H, Shaw R, Jaime Dauden E-A et al (2018) Understanding frailty: a qualitative study of European healthcare policy-makers’ approaches to frailty screening and management. BMJ Open 8:e018653. https://doi.org/10.1136/bmjopen-2017-018653
Ikawa F, Isobe N, Michihata N et al (2021) In-Hospital Complications After Surgery in Elderly Patients with Asymptomatic or Minor Symptom Meningioma: A Nationwide Registry Study. World Neurosurgery 148:e459–e470. https://doi.org/10.1016/j.wneu.2021.01.001
Jackson HN, Hadley CC, Khan AB et al (2022) Racial and Socioeconomic Disparities in Patients With Meningioma: A Retrospective Cohort Study. Neurosurgery 90:114–123. https://doi.org/10.1227/NEU.0000000000001751
Kent CL, Mowery YM, Babatunde O et al (2022) Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution Experience. Adv Radiat Oncol 7:100878. https://doi.org/10.1016/j.adro.2021.100878
Kshettry VR, Ostrom QT, Kruchko C et al (2015) Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro Oncol 17:1166–1173. https://doi.org/10.1093/neuonc/nov069
Lei H, Tabor JK, O’Brien J et al (2023) Associations of race and socioeconomic status with outcomes after intracranial meningioma resection: a systematic review and meta-analysis. J Neurooncol 163:529–539. https://doi.org/10.1007/s11060-023-04393-5
Li D, Jiang P, Xu S et al (2019) Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas. J Neurooncol 145:125–134. https://doi.org/10.1007/s11060-019-03278-w
Liang R-F, **u Y-J, Wang X et al (2014) The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases. Int J Clin Exp Med 7:5696–5700
Lim WS, Wong SF, Leong I et al (2017) Forging a Frailty-Ready Healthcare System to Meet Population Ageing. Int J Environ Res Public Health 14:1448. https://doi.org/10.3390/ijerph14121448
Lin D, Lin J, Deng X et al (2019) Trends in intracranial meningioma incidence in the United States, 2004–2015. Cancer Med 8:6458–6467. https://doi.org/10.1002/cam4.2516
Liu F, Tang X, Wang X et al (2021) High-grade meningiomas in octogenarian and elderly patients: A population-based SEER analysis. J Clin Neurosci 89:165–170. https://doi.org/10.1016/j.jocn.2021.04.041
Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol 114:97–109. https://doi.org/10.1007/s00401-007-0243-4
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
Mallin K, Browner A, Palis B et al (2019) Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012–2014. Ann Surg Oncol 26:1604–1612. https://doi.org/10.1245/s10434-019-07213-1
Merkow RP, Rademaker AW, Bilimoria KY (2018) Practical Guide to Surgical Data Sets: National Cancer Database (NCDB). JAMA Surg 153:850. https://doi.org/10.1001/jamasurg.2018.0492
Mokhtari S, Peeri NC, Beer-Furlan A, Anderson MD, Chowdhary S, LaRocca RV, Mammoser AG et al (2023) Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series. Br J Neurosurg 1–4. https://doi.org/10.1080/02688697.2023.2219759
Nakasu S, Notsu A, Na K, Nakasu Y (2020) Malignant transformation of WHO grade I meningiomas after surgery or radiosurgery: systematic review and meta-analysis of observational studies. Neuro-Oncol Adv 2:vdaa129. https://doi.org/10.1093/noajnl/vdaa129
Nayeri A, Brinson P, Weaver K et al (2015) Factors Associated with Low Socioeconomic Status Predict Poor Postoperative Follow-up after Meningioma Resection. J Neurol Surg B 77:226–230. https://doi.org/10.1055/s-0035-1566122
Orton A, Frandsen J, Jensen R et al (2018) Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012. J Neurosurg 128:1684–1689. https://doi.org/10.3171/2017.2.JNS162282
Poon MT-C, Fung LH-K, Pu JK-S, Leung GK-K (2014) Outcome of elderly patients undergoing intracranial meningioma resection – A systematic review and meta-analysis. Br J Neurosurg 28:303–309. https://doi.org/10.3109/02688697.2013.841857
Rafiq R, Katiyar V, Garg K et al (2021) Comparison of outcomes of surgery for intracranial meningioma in elderly and young patients – A systematic review and meta-analysis. Clin Neurol Neurosurg 207:106772. https://doi.org/10.1016/j.clineuro.2021.106772
Recker MJ, Kuo CC, Prasad D et al (2022) Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018. J Neurooncol 160:13–22. https://doi.org/10.1007/s11060-022-04085-6
Rogers CL, Won M, Vogelbaum MA et al (2020) High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539. Int J Radiat Oncol* Biol* Phys 106:790–799. https://doi.org/10.1016/j.ijrobp.2019.11.028
Soni P, Davison MA, Shao J et al (2021) Extent of resection and survival outcomes in World Health Organization grade II meningiomas. J Neurooncol 151:173–179. https://doi.org/10.1007/s11060-020-03632-3
Steinberger J, Bronheim RS, Vempati P et al (2018) Morbidity and Mortality of Meningioma Resection Increases in Octogenarians. World Neurosurg 109:e16–e23. https://doi.org/10.1016/j.wneu.2017.09.021
Troya Castilla M, Chocrón Gonzalez Y, Márquez Rivas FJ (2016) Complicaciones y pronóstico de pacientes ancianos diagnosticados de meningioma intracraneal. Rev Esp Geriatr Gerontol 51:82–87. https://doi.org/10.1016/j.regg.2015.06.004
Vagnoni L, Aburas S, Giraffa M et al (2022) Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues. Neurosurg Rev 45:3019–3033. https://doi.org/10.1007/s10143-022-01806-3
Vuong HG, Ngo TNM, Dunn IF (2021) Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation. Neuro-Oncol Adv 3:vdab084. https://doi.org/10.1093/noajnl/vdab084
Walcott BP, Nahed BV, Brastianos PK, Loeffler JS (2013) Radiation treatment for WHO grade II and III meningiomas. Front Oncol 3:227. https://doi.org/10.3389/fonc.2013.00227
Wang Y-C, Chuang C-C, Wei K-C et al (2016) Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas. Sci Rep 6:35743. https://doi.org/10.1038/srep35743
Wang K, Liu H, Hu Q et al (2022) Epigenetic regulation of aging: implications for interventions of aging and diseases. Sig Transduct Target Ther 7:374. https://doi.org/10.1038/s41392-022-01211-8
Wang JZ, Nassiri F, Landry AP et al (2023) Fractionated radiotherapy for surgically resected intracranial meningiomas: A multicentre retrospective cohort study. Radiother Oncol 188:109861. https://doi.org/10.1016/j.radonc.2023.109861
Wedemeyer MA, Muskens I, Strickland BA et al (2022) Epigenetic dysregulation in meningiomas. Neuro-Oncology. Advances 4:vdac084. https://doi.org/10.1093/noajnl/vdac084
Yang AI, Mensah-Brown KG, Rinehart C et al (2020) Inequalities in Meningioma Survival: Results from the National Cancer Database. Cureus. https://doi.org/10.7759/cureus.7304
Zhu H, Bi WL, Aizer A et al (2019) Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Med 8:13–20. https://doi.org/10.1002/cam4.1531
Acknowledgements
None.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
Conceptualization, MK, and KM.; Methodology, MK, and KM; Software, MK; Formal Analysis, MK; Data Curation, MK; Writing – Original Draft Preparation, ML, MK, OM, and PJ; Writing – Review & Editing, MK, RS, and KM; Visualization, MK; Supervision, KM; Project Administration, MK, and KM.
Corresponding author
Ethics declarations
Ethics approval
The study was deemed exempt by the Icahn School of Medicine at Mount Sinai's institutional review board.
Statement for NCDB
The Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society is the source of the data used herein; none of these institutions verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Karabacak, M., Lampros, M., Mavridis, O. et al. Atypical and anaplastic meningiomas in the later decades of life: A national cancer database analysis. Acta Neurochir 166, 282 (2024). https://doi.org/10.1007/s00701-024-06157-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00701-024-06157-0